| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |